ArticleJournal for immunotherapy of cancer2024

Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer.

Liang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.